Nanotechnology Now - Press Release: 180 Degree Capital Corp.

Nanotechnology Now - Press Release: 180 Degree Capital Corp. Reports +14.2% Growth in Q1 2021, $10.60 Net Asset Value Per Share as of March 31, 2021, and Developments From Q2 2021


Nanotechnology Now
Our NanoNews Digest Sponsors
Home > Press > 180 Degree Capital Corp. Reports +14.2% Growth in Q1 2021, $10.60 Net Asset Value Per Share as of March 31, 2021, and Developments From Q2 2021
Abstract:
180 Degree Capital Corp. (NASDAQ:TURN) (“180” and the “Company”), today reported its financial results as of March 31, 2021, and additional developments from the second quarter of 2021. The Company also published a letter to shareholders that can be viewed at https://ir.180degreecapital.com/financial-results .
180 Degree Capital Corp. Reports +14.2% Growth in Q1 2021, $10.60 Net Asset Value Per Share as of March 31, 2021, and Developments From Q2 2021
Montclair, NJ | Posted on May 11th, 2021
“I am pleased to report continued growth in our net asset value per share (NAV) as of March 31, 2021, to $10.60, the highest level in over six years,” said Kevin M. Rendino, Chief Executive Officer of 180. “This growth was powered by our continued strong performance in our public market investment strategy that generated a gross total return of +28.3% in the first quarter of 2021.1 Our separately managed account (SMA) had strong performance as well, generating a gross total return of +20.7%. If this were the end of 2021, we would generate approximately $2 million in carried interest from the SMA, and net performance for the SMA would be 14.5%.2 I remind investors that this potential carried interest is not included in our reported NAV as of the end of the first quarter of 2021. We ended the quarter with approximately $114 million in assets under management in aggregate in 180 and our SMA, available to be deployed in our public market investment strategy. I am proud of this 5.5x increase in scale we have built at 180 since starting in 2017. We continue to believe our Graham and Dodd investment philosophy, coupled with our activist approach, will lead to enhanced shareholder value creation for all of our TURN shareholders.”

Related Keywords

Kevinm Rendino , Danielb Wolfe , , Exchange Commission , Evaluation Committee , Arrowhead Pharmaceuticals To Webcast Fiscal , Degree Capital Corp , Wave Inc , Nasdaq , Shareholders Of Enzo Biochem Inc , Asset Value Per Share , Chief Executive Officer , Portfolio Gross Total Return , Stock Price , Micro Cap Index , Microcap Value Index , Eastern Time , Nanotechnology Now , Issues Second Open Letter , Enzo Biochem , Report Fourth Quarter , Conference Call , Webcast Fiscal , Quarter Results April , பரிமாற்றம் தரகு , மதிப்பீடு குழு , பட்டம் மூலதனம் கார்ப் , அலை இன்க் , நாஸ்டாக் , பங்குதாரர்கள் ஆஃப் என்ஸோ உயிர் வேதியியல் இன்க் , சொத்து மதிப்பு ஒன்றுக்கு பகிர் , தலைமை நிர்வாகி அதிகாரி , போர்ட்‌ஃபோலீயோ மொத்த மொத்தம் திரும்ப , ஸ்டாக் ப்ரைஸ் , மைக்ரோ தொப்பி குறியீட்டு , கிழக்கு நேரம் , நானோ தொழில்நுட்பம் இப்போது , சிக்கல்கள் இரண்டாவது திறந்த கடிதம் , என்ஸோ உயிர் வேதியியல் , அறிக்கை நான்காவது காலாண்டு , மாநாடு அழைப்பு ,

© 2025 Vimarsana